Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables
Authors:
- Clyde M OfnerCOClyde M Ofner
- 1 June 2000
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 204 (1-2) , 81-89
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Biodegradable microspheres using two different gelatin drug conjugates for the controlled delivery of methotrexateInternational Journal of Pharmaceutics, 1996
- Body distribution of intravenously administered gelatin with different molecular weightsJournal of Controlled Release, 1994
- Preparation, characterisation and in vitro stability of hydrophilic gelatin microspheres using a gelatin-methotrexate conjugateInternational Journal of Pharmaceutics, 1993
- Potentiation of in vivo Antitumor Effects of Recombinant Interleukin‐1α by Gelatin ConjugationJapanese Journal of Cancer Research, 1993
- Suppressive Effect of Recombinant TNF-gelatin Conjugate on Murine Tumour Growth In-vivoJournal of Pharmacy and Pharmacology, 1993
- Potentiation of Antitumor Activity of Macrophages by Recombinant Interferon Alpha A/D Contained in Gelatin MicrospheresJapanese Journal of Cancer Research, 1988
- Characterization of in-vitro drug release and biological activity of methotrexate-bovine serum albumin conjugatesJournal of Pharmacy and Pharmacology, 1987
- Reconstituted collagen nanoparticles, a novel drug carrier delivery systemJournal of Pharmacy and Pharmacology, 1983
- Specific delivery of mitomycin c to the liver, spleen and lung: Nano- and m1crospherical carriers of gelatinInternational Journal of Pharmaceutics, 1981
- Increased lymphatic delivery of bleomycin by microsphere in oil emulsion and its effect on lymph node metastasisInternational Journal of Pharmaceutics, 1979